How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases.
Here we describe a protocol that can be used to study the biophysical microenvironment related to increased thickness and stiffness of the basement membrane (BM) during age-related pathologies and metabolic disorders (e.g. cancer, diabetes, microvascular disease, retinopathy, nephropathy and neuropathy). The premise of the model is non-enzymatic crosslinking of reconstituted BM (rBM) matrix by treatment with glycolaldehyde (GLA) to promote advanced glycation endproduct (AGE) generation via the Maillard reaction. Examples of laboratory techniques that can be used to confirm AGE generation, non-enzymatic crosslinking and increased stiffness in GLA treated rBM are outlined. These include preparation of native rBM (treated with phosphate-buffered saline, PBS) and stiff rBM (treated with GLA) for determination of: its AGE content by photometric analysis and immunofluorescent microscopy, its non-enzymatic crosslinking by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE) as well as confocal microscopy, and its increased stiffness using rheometry. The procedure described here can be used to increase the rigidity (elastic moduli, E) of rBM up to 3.2-fold, consistent with measurements made in healthy versus diseased human prostate tissue. To recreate the biophysical microenvironment associated with the aging and diseased prostate gland three prostate cell types were introduced on to native rBM and stiff rBM: RWPE-1, prostate epithelial cells (PECs) derived from a normal prostate gland; BPH-1, PECs derived from a prostate gland affected by benign prostatic hyperplasia (BPH); and PC3, metastatic cells derived from a secondary bone tumor originating from prostate cancer. Multiple parameters can be measured, including the size, shape and invasive characteristics of the 3D glandular acini formed by RWPE-1 and BPH-1 on native versus stiff rBM, and average cell length, migratory velocity and persistence of cell movement of 3D spheroids formed by PC3 cells under the same conditions. Cell signaling pathways and the subcellular localization of proteins can also be assessed.
Departamento de Genética, Facultad de Medicina, Universidad de la República (UDELAR).
Mercedes
M
Rodriguez-Teja
Department of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology.
Claudia
C
Breit
School of Biological, Biomedical & Environmental Sciences, University of Hull.
Mitchell
M
Clarke
School of Biological, Biomedical & Environmental Sciences, University of Hull.
Kamil
K
Talar
School of Biological, Biomedical & Environmental Sciences, University of Hull.
Kai
K
Wang
School of Biological, Biomedical & Environmental Sciences, University of Hull.
Mohammad A
MA
Mohammad
School of Biological, Biomedical & Environmental Sciences, University of Hull.
Sage
S
Pickwell
Departamento de Genética, Facultad de Medicina, Universidad de la República (UDELAR).
Guillermina
G
Etchandy
School of Biological, Biomedical & Environmental Sciences, University of Hull.
Graeme J
GJ
Stasiuk
School of Biological, Biomedical & Environmental Sciences, University of Hull; J.Sturge@hull.ac.uk.
Justin
J
Sturge
D001485:Basement Membrane; D004548:Elasticity; D005109:Extracellular Matrix; D006801:Humans; D008297:Male; D008659:Metabolic Diseases; D011467:Prostate; D011470:Prostatic Hyperplasia; D011471:Prostatic Neoplasms
Clin Exp Metastasis. 2016 Feb;33(2):151-65
26567111
Cell Adh Migr. 2013 Jan-Feb;7(1):64-71
23154404
Exp Eye Res. 2013 Nov;116:298-307
24095823
Nature. 1970 Aug 15;227(5259):680-5
5432063
J Cell Biol. 2006 Oct 23;175(2):337-47
17043135
Bioessays. 1996 Feb;18(2):123-32
8851045
Electrophoresis. 1990 Oct;11(10):785-94
1706657
Int J Endocrinol. 2014;2014:329456
24688539
Ultrason Imaging. 1998 Oct;20(4):260-74
10197347
J Pathol. 2015 Mar;235(4):581-92
25408555
Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4
388439
Cancer Biomark. 2008;4(4-5):213-25
18957712
Am J Pathol. 1988 Aug;132(2):278-91
3400773
Oncogene. 2013 Apr 4;32(14):1863-8
22641216
Med Eng Phys. 2011 Apr;33(3):302-9
21093348
Invest Urol. 1979 Jul;17(1):16-23
447482
Carcinogenesis. 1997 Jun;18(6):1215-23
9214605
Mol Cancer Res. 2015 Mar;13(3):538-47
25381222
In Vitro Cell Dev Biol Anim. 1995 Jan;31(1):14-24
7535634
Cell. 2009 Nov 25;139(5):891-906
19931152
Methods Mol Biol. 2010;591:211-27
19957133
Cancer Cell. 2005 Sep;8(3):241-54
16169468
Matrix Biol. 2010 Jun;29(5):402-10
20362054
Methods. 2003 Jul;30(3):256-68
12798140
Ultrasound Med Biol. 2008 Jul;34(7):1033-42
18258350
J Cell Biol. 2003 Sep 1;162(5):789-94
12952933